Aster Launched Perpetual Contract for Oura Health IPO

Traders can now speculate on Oura's upcoming Nasdaq debut using crypto-native perpetual contracts with 20x leverage.

Updated on Sept. 23, 2026 in Healthcare

Isometric editorial illustration of a glass wafer balanced on a pedestal, representing abstract financial market risk. — Aster launched a new perpetual contract allowing traders to speculate on Oura Health's pre-IPO valuation using USD1 stablecoin settlement. AI Illustration. Upload story photo >

Live Poll

Do you trust decentralized platforms that allow leveraged speculation on pre-IPO company valuations?

Aster introduced an OURA/USD1 perpetual contract as Oura Health commenced its roadshow for a proposed 50-million-share Nasdaq listing. This financial instrument allows crypto-native traders to gain exposure to the IPO's market-implied pricing using USD1 stablecoin settlement.

Why it matters

The contract offers crypto-market participants access to pre-IPO price action traditionally restricted to accredited investors. It highlights an expanding trend of bridging real-world asset valuations into decentralized finance ecosystems.

Oura Health is targeting a fully diluted valuation of $14.1 billion to $15.6 billion on 50 million shares. The Aster perpetual contract provides 20x leverage, though a 5% adverse price move triggers total stake liquidation.

The players

Oura Health

A Finland-based health technology company currently targeting a Nasdaq public listing.

Aster

A trading platform that enables crypto-native derivatives and perpetual contracts for pre-IPO assets.

The details

The perpetual contract tracks the market-implied price per share without granting actual equity ownership in the firm. Traders must use the USD1 stablecoin to settle all positions, a mechanism designed to incentivize stablecoin adoption for real-world asset products. The platform previously utilized this model for SpaceX and OpenAI pre-IPO derivatives in 2026.

September 21, 2026: Oura Health began its IPO roadshow.
September 23, 2026: Aster launched the OURA/USD1 perpetual contract.
December 31, 2026: The Aster USD1 RWA Boost rewards campaign ends.

Public Companies
Sept. 21
Oura Announced IPO Plans to Raise $2.2 Billion
Inflation
Sept. 18
Fed Raised Rates 25 Basis Points to 4%
Financial Services
Sept. 18
BlackRock Defined Stablecoin Utility Standards

Market Landscape

This move follows Aster's 2026 launch of pre-IPO perpetuals for SpaceX and OpenAI, cementing a strategy of offering crypto-accessible derivatives for high-profile private company exits. The trend signals a persistent demand from crypto-native traders for exposure to traditional equity valuation cycles.

Operators tracking Oura's public entry should treat these perpetual contract prices as a volatile sentiment indicator rather than a firm valuation signal. Owners and managers should recognize that such contracts increase public attention and market-implied pressure on the company ahead of its Nasdaq debut.

The takeaway

The rise of pre-IPO perpetual contracts creates a new parallel market where price discovery can occur before the public listing date. Managers should monitor how these speculative, high-leverage products influence public perception and potential volatility during the initial days of a company's trading.